Mprex Healthcare

07/04/2025

It was a true pleasure for the Mprex Team to meet Ms. Rupal Mehta., Founder of MedMarvel Software Solutions. MedMarvel has established collaborations with 15 hospitals and over 50 doctors across the United States, reinforcing their commitment to quality and trust. More than just a service provider, MedMarvel acts as a strategic partner in client growth. With deep expertise in healthcare IT, medical product development, and outsourcing, the company delivers tailored solutions that improve operational efficiency, ensure compliance, and enhance patient outcomes.

With a strong presence in India and 24/7 operations, they provide seamless support to healthcare organizations worldwide—including night shift and weekend overflow coverage for US-based practices.

07/04/2025

We had the pleasure of attending the launch event for The Good Bug’s flagship product for weight loss. It was a great opportunity to meet Prabhu Karthikeyan, the founder of The Good Bug.

A proud moment for the entire team as they enter the weight-loss segment with a first-of-its-kind, clinically tested breakthrough product—combining probiotics and prebiotic fiber to support natural, sustainable weight management.

07/04/2025

22/03/2025

Mprex Healthcare is thrilled to announce a significant collaboration! We recently had the privilege of hosting Dr. Dipika Gunawant, associated with DS Group, and Mr. Ashwani Kumar Roy, Deputy Manager at DS Group, at our corporate office.

The purpose of their visit was to explore potential clinical trial associations with Mprex. We are delighted to share that we will be partnering with DS Group on groundbreaking research in the field of nutraceuticals.

This collaboration marks an exciting milestone for Mprex, and we look forward to contributing our expertise to drive innovation in the healthcare industry. We are eager to work together with DS Group to advance the science behind nutraceuticals and improve lives worldwide.

19/03/2025

Mprex recently attended BNI Elite, a premier Business Network International (BNI) event held in Pune. This prestigious gathering brought together influential dignitaries and business leaders to explore opportunities for collaboration and acquisition, aiming to accelerate business growth.

During the event, industry experts emphasized how collaboration can significantly enhance business speed and open up new avenues for expansion. By partnering with the right organizations, companies can leverage each other’s strengths, resources, and networks to achieve mutual success. Collaboration fosters innovation, improves market reach, and helps businesses stay competitive in a dynamic market.

Additionally, discussions around acquisition highlighted its potential to strengthen internal capabilities. Acquiring businesses can lead to increased operational efficiency, access to new technologies, and a broader customer base. It also fortifies a company’s market position by reducing competition and streamlining resources.

Mprex’s participation in BNI Elite reinforced its commitment to strategic growth and business excellence. Engaging with industry leaders provided valuable insights and opportunities to explore partnerships that align with its vision. By embracing collaboration and acquisition strategies, Mprex aims to expand its influence, enhance operational strength, and drive long-term success in an evolving business landscape.

09/03/2025

Celebrating the strength, resilience, and achievements of the incredible women in our workplace! ✨ Happy Women's Day 2025!

08/03/2025

A big salute to the women who make life so special with their love and strength. Happy Women's Day!

19/02/2025

Chatrapati Shivaji Maharaj is the symbol of courage, strength, and justice. Let us remember his sacrifices and honour his leadership.
3m

05/02/2025

Advancing Cancer Care: The Power of Clinical Trials on World Cancer Day

World Cancer Day, observed every year on February 4th, is a global initiative to raise awareness, encourage prevention, and promote advancements in cancer treatment. With millions of people affected by cancer worldwide, this day serves as a reminder of the urgent need for continued research, early detection, and access to effective treatments. One of the most significant contributors to cancer advancements is clinical trials. These trials are essential in developing new and improved cancer treatments, testing innovative drugs, and finding more effective therapies with fewer side effects. Clinical trials provide hope for patients by offering access to cutting-edge treatments before they become widely available. Mprex Healthcare is making remarkable contributions to cancer clinical trials, playing a key role in advancing cancer research. By conducting high-quality, patient-centric clinical trials, Mprex Healthcare is helping to bring innovative therapies to those who need them most. Their work not only accelerates the development of breakthrough treatments but also ensures that patients receive the best possible care. As we observe World Cancer Day, it is crucial to support organizations like Mprex Healthcare, whose dedication to clinical research is transforming the future of cancer treatment and saving lives.

26/01/2025

This Republic Day, let us proudly celebrate the spirit of our Constitution, honoring the visionaries and brave souls whose sacrifices and wisdom laid the foundation of justice, equality, and freedom for all.

23/01/2025

A team of Mcare Pathology and Research Center, (Mprex's own venture and pathology chain) recently visited our new corporate office. The Mcare team met with Mprex's Clinical Research team, facilitating a valuable exchange of ideas and expertise. During the meeting, both teams shared their respective areas of research focus and highlighted their achievements from the past year.

The discussion was fruitful, with both teams identifying potential areas of collaboration and synergies. This meeting marked a significant step in strengthening the partnership between Mcare and Mprex. By combining their expertise, they aim to drive innovation in clinical research and contribute to the development of new treatments and therapies.

The collaboration is expected to yield benefits for both parties, enabling them to expand their service offerings and enhance their research capabilities. With a shared commitment to excellence and innovation, Mcare and Mprex are poised to make a meaningful impact in the field of clinical research.

23/01/2025

We are pleased to announce that Mprex has officially collaborated with PreclinBio Solutions, a renowned expert in in vitro and ex vivo studies. This strategic partnership brings together the expertise of Mr. Vinod and Mr. Anand, further enhancing Mprex's capabilities.

Through this collaboration, Mprex expands its service portfolio, offering a broader range of solutions to our global and Indian clients, with a specific focus on cancer, cardiovascular, and CNS drugs research. This partnership reinforces our commitment to delivering exceptional value and expertise to our clients.

We look forward to leveraging this collaboration to drive innovation and excellence in our services.